Share Name Share Symbol Market Type Share ISIN Share Description
Gyg PLC LSE:GYG London Ordinary Share GB00BZ4FM652 ORD GBP0.002
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 133.50p 132.00p 135.00p 134.00p 133.50p 133.50p 4,741 14:00:27
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Industrial Transportation - - - - 62.26

Gyg PLC (GYG) Latest News

More Gyg PLC News
Gyg PLC Takeover Rumours

Gyg PLC (GYG) Share Charts

1 Year Gyg PLC Chart

1 Year Gyg PLC Chart

1 Month Gyg PLC Chart

1 Month Gyg PLC Chart

Intraday Gyg PLC Chart

Intraday Gyg PLC Chart

Gyg PLC (GYG) Discussions and Chat

Gyg PLC Forums and Chat

Date Time Title Posts
30/10/201709:52***GYG ***46
31/1/200821:13Gyrus Group 2006291
18/7/200709:51Gyrus group.6
24/3/200620:47gyrus read this88
16/3/200511:17gryus read this-

Add a New Thread

Gyg PLC (GYG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2017-11-17 14:28:07133.00715950.95O
2017-11-17 12:54:30134.70153206.09O
2017-11-17 12:28:25133.00381506.73O
2017-11-17 08:18:33133.003,4924,644.36O
View all Gyg PLC trades in real-time

Gyg PLC (GYG) Top Chat Posts

Gyg PLC Daily Update: Gyg PLC is listed in the Industrial Transportation sector of the London Stock Exchange with ticker GYG. The last closing price for Gyg PLC was 133.50p.
Gyg PLC has a 4 week average price of 127.50p and a 12 week average price of 117.50p.
The 1 year high share price is 629.50p while the 1 year low share price is currently 104.50p.
There are currently 46,640,000 shares in issue and the average daily traded volume is 25,707 shares. The market capitalisation of Gyg PLC is £62,264,400.
mrnumpty: jonwig , thanks for such a prompt and informative reply , in which you are more candid than I had expected by revealing your purchase price . As you write , there seems to be a good chance of further share price growth , and I have just read a report suggesting a valuation of £ 105m , about 1.6 times the current value . Nonetheless , we both know the mantra of " do your own research " . Although I read all of your comments on the Burford Capital ADFN bulletin board , I have rarely posted as I am somewhat in awe of your expertise . Anyway , many thanks again , and good LUCK ( I think my typo might have been Freudian ! ) to us all . Oh , finally , do you have any thoughts concerning how this stock would respond to a market downturn - on the one hand , one might think that the rich will always have money to pay for their yachts and yet , on the other hand even they might reduce their expenditure in a downturn . As I wrote before , any decisions and inferences which I make are my own responsibility , as we are all adults .
jonwig: Hi, numpty. I make a point of checking for future IPOs, and then read their prospectuses. GYG struck me as a sound established business with good management, though I wan't able to be in the placing. I waited a bit then bought some in July at 115p. After each set of results I tend to double, hold, halve or quit (you know the kind of thinking). In this case it's hold since the price has been run up quite a bit through tips. If Zeus are to believed, there's another 100p to come on the share price. And ST's comments look pretty accurate. Equity Development have an excellent research report for free, dated 5 July.
its the oxman: Positive outlook and results - steady climb in the share price looks likely to continue.
jonwig: H1 results: Https:// Zeus Capital: We are comfortable with the H2 weighting implied by this performance relative to last year. We are also encouraged by the growth in order book since June, back with a record pipeline. The market also continues to grow as expected with superyacht numbers currently at record levels. At the current share price GYG trades on a 2017E P/E of 14.7x (falling to 11.9x in 2018E) and an EV/EBITDA of 10.0x (falling to 7.8x in 2018E), which we believe is compelling in the context of a 5.0% yield from 2018E. Our valuation is also supported by our DCF and intrinsic value analysis, which implies a valuation over €120m (£105m) if the strategy is executed successfully. Overall we believe these are a robust set of results, with GYG well positioned to hit our FY forecast assumptions, and set for attractive medium term growth.
jonwig: Their NOMAD Zeus Capital has produced a very positive 44-page note implying H1 results are imminent, and won't have any upsets. Summary: At the current share price GYG trades on a 2017E P/E of 12.4x (falling to 10.0x in 2018E) and an EV/EBITDA of 8.6x (falling to 6.6x in 2018E), which we believe is compelling in the context of a 5.6% yield from 2018E. Our valuation is also supported by our DCF and intrinsic value analysis, which implies a valuation over €120m (£109m) if the strategy is executed successfully. A valuation of £109m would be a share price of 233p (!)
maddox: Rivaldo, Agreed, I would have expected anoter bidder to have thrown their hat into the ring by now. Also, the share price would have signalled an interest. This looks like a done deal. Regards, Maddox
rivaldo: The offer document's being published, so the Offer looks nailed on - getting a bit late for other approaches now. The share price should now approach the full 630p offered.
grigor: ... The offer, which values Gyrus at £935m, could be high enough to ward off interest from other bidders, although Paul Cuddon, an analyst at KBC Peel Hunt, said that Johnson & Johnson is unlikely to be comfortable with Olympus entering the market for general electrosurgical devices and may consider a counter-bid. Companies such as Stryker, ValleyLab and Pentax were also seen as possible suitors to rival the Japanese company's ambition. Mr Cudden said that some interested parties may have been surprised by the speed at which Olympus has done the deal, and that until the takeover completes, there is room for further share price upside. Any rival bid is likely could be complicated by the US regulators, due to the overlap in the major players' operations. The Nomura analyst Michael King said that the likes of Karl Storz, a leading supplier to the urology and gynaecology markets, may be interested in Gyrus, but the overlap may be too great for US regulators. For Olympus, the overlap between the two businesses is not as stark, with the Japanese company strongest in Japan and Europe, while Gyrus has a more dominant position in the US. ...
maddox: Wad, Not impressed by these results. I was expecting the dollar effect but the underlying growth is less than I expected. The share price fall also leads me to believe that they have not done anything to lower expectations ahead of these figures. With the Analysts giving a rosey picture, as Rivaldo has posted above, this disappointed reaction was a given. It doesn't pay to undermine the Analyst's confidence in the management team. Regards, Maddox
rivaldo: Stick with it wad collector imo - short-term is irrelevant if you're after decent gains of 50% or more as probably most of us on this thread have. For example, from yesterday: "Gyrus Posted on September 11th, 2007 in Market whispers. Morgan Stanley says the recent share price decline presents a buying opportunity. With a price target of 517p, broker says: 'Although Gyrus has experienced more than 10% share price decline in the last two months, we believe there is no fundamental reason for this.'"
Gyg PLC share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20171118 08:21:36